NIAID renews funding for the adult AIDS clinical trials group
Sweeney, R.; Rose, V.L.
American Family Physician 61(4): 940
2000
ISSN/ISBN: 0002-838X PMID: 10706147 Document Number: 512632
Document emailed within 1 workday
Related Documents
Gordin, F.; Chaisson, R.E.; Matts, J.P.; Miller, C.; de Lourdes Garcia, M.; Hafner, R.; Valdespino, J.L.; Coberly, J.; Schechter, M.; Klukowicz, A.J.; Barry, M.A.; O'Brien, R.J. 2000: Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group JAMA 283(11): 1445-1450Shilling, R.A.; Subramanian, N.; Dowlati, A.; Gordon, S.; Ramnes, C.; Sedransk, N.; Lederman, M.; Remick, S.C. 1999: A composite clinical stage for AIDS-related Kaposis sarcoma A refinement of the AIDS clinical trials group clinical staging classification JAIDS Journal of Acquired Immune Deficiency Syndromes 21(1): A23
Benson, C.A.; Williams, P.L.; Cohn, D.L.; Becker, S.; Hojczyk, P.; Nevin, T.; Korvick, J.A.; Heifets, L.; Child, C.C.; Lederman, M.M.; Reichman, R.C.; Powderly, W.G.; Notario, G.F.; Wynne, B.A.; Hafner, R. 2000: Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team Journal of Infectious Diseases 181(4): 1289-1297
Hochster, H.; Dieterich, D.; Bozzette, S.; Reichman, R.C.; Connor, J.D.; Liebes, L.; Sonke, R.L.; Spector, S.A.; Valentine, F.; Pettinelli, C. 1990: Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study Annals of Internal Medicine 113(2): 111-117
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Hoelzer, D.; Thiel, E.; Ludwig, W.D.; Löffler, H.; Büchner, T.; Freund, M.; Heil, G.; Hiddemann, W.; Maschmeyer, G.; Völkers, B. 1993: Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group Leukemia 7(Suppl 2): S130-S134
Feigal, E.G.; Phillips, P.H.; Cheson, B.D. 1997: Clinical Trials Referral Resource. Clinical trials in AIDS related malignancies Oncology 11(3): 337-338; 341
Rutstein, R.M.; Samson, P.; Fenton, T.; Fletcher, C.V.; Kiser, J.J.; Mofenson, L.M.; Smith, E.; Graham, B.; Mathew, M.; Aldrovani, G.; Rutstein, R.M.; Douglas, S.; Aldrovandi, G.; Kiser, J.; Fletcher, C.V.; Fenton, T.; Samson, P.; Graham, B.; Sprenger, H.L.; Mofenson, L.M.; Smith, E.; Purdue, L.; Kneut, C.; Ortiz, B.; Douglas, Q.; Petzold, E.; Myers, T.; Violari, A.; Gray, G.; Horga, M.; Schnittman, S.; Matthew, M.; Dieudonne, A.; Johnson, J.; Monti, L.; Bryson, Y.; Deville, J.G.; Nielsen-Saines, K.; Paul, M.; Hammill, H.; McMullen-Jackson, C.; Yogev, R.; Cagwin, E.; Williams, R.; Spector, S.A.; Viani, R.M.; Stangl, L.; Swetnam, J.; Wilson, J.; Donnelly, M.; Abrams, E.; Frere, M.; Calo, D.; Pelton, S.I.; McLaud, D.; Tucker, L.; Borkowsky, W 2015: Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A Pediatric Infectious Disease Journal 34(2): 162-167
Dolin, R.; Amato, D.A.; Fischl, M.A.; Pettinelli, C.; Beltangady, M.; Liou, S.H.; Brown, M.J.; Cross, A.P.; Hirsch, M.S.; Hardy, W.D. 1995: Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group Archives of Internal Medicine 155(9): 961-974
1998: Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations Journal of Clinical Psychiatry 59 Suppl. 12: 23-27
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379
Ehrhardt, A.A.; Fishbein, M.; Washington, E.; Smith, W.; Holmes, K.K. 1990: The NIAID Study Group on Integrated Behavioral Research for Prevention and Control of Sexually Transmitted Diseases. Part II: Issues in designing behavioral interventions Sexually Transmitted Diseases 17(4): 204-207
Demartoto, A.; Murti, B.; Zunariyah, S. 2021: HIV/AIDS treatment funding system to support the people affected by HIV/AIDS in Surakarta, Indonesia Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 18(1): 1-16
van der Heide, A.; Jacobs, J.W.; Schenk, Y.; Bijlsma, J.W. 1994: Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis Journal of Rheumatology 21(12): 2195-2199
Avent, R.; Birch, R.; Oldham, R.K.; Arnold, J. 1990: Successful clinical trials in the private sector: the National Biotherapy Study Group (NBSG) experience Progress in Clinical and Biological Research 339: 419-423
Wu, D.; Zhao, Y.; Liu, H.; Yin, W.; Zhang, D.; Li, H.; Hu, Y. 2015: Allocation analysis of central government AIDS special funding in priority sites of HIV/AIDS prevention and control Zhonghua Yu Fang Yi Xue Za Zhi 49(6): 496-500
Oliveira, M.A.; Santos, E.M.; Mello, J.M. 2001: AIDS, activism, and the regulation of clinical trials in Brazil: Protocol 028 Cadernos de Saude Publica 17(4): 863-875
Nowak, R. 1995: AIDS researchers, activists fight crisis in clinical trials Science 269(5231): 1666-1667